FluoroPharma Medical, Inc.
FPMI
Rank in Stocks
#34569
FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the... FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$6.81K
Change (1 day)
0.00%
Change (1 year)
100.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade FluoroPharma Medical, Inc. (FPMI)
Category
Healthcare
Operating Margin for FluoroPharma Medical, Inc. (FPMI)
Operating Margin as of November 2026 TTM: 0.00%
According to FluoroPharma Medical, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2016 the company had an operating margin of 0.00%.
Operating Margin history for FluoroPharma Medical, Inc. from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
| 2009 | 0.00% | -100.00% |
| 2008 | -8.44% | -86.69% |
| 2007 | -63.41% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 31.23% | - |
BE
|
|
| 29.35% | - |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about FluoroPharma Medical, Inc.'s operating margin
What was FluoroPharma Medical, Inc.'s operating margin in 2016?
In 2016, FluoroPharma Medical, Inc.'s operating margin was 0.00%, compared with 0.00% in 2015.
How has FluoroPharma Medical, Inc.'s operating margin changed since 2011?
From 2011 to 2016, FluoroPharma Medical, Inc.'s operating margin was highest in 2016 (0.00%) and lowest in 2016 (0.00%).
How does FluoroPharma Medical, Inc.'s operating margin compare with similar companies?
FluoroPharma Medical, Inc.'s operating margin (0.00%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.